Print Page  Close Window

SEC Filings

10-K
DITECH HOLDING CORP filed this Form 10-K on 04/16/2019
Entire Document
 


TABLE OF CONTENTS
PAGE
SECTION 1. CREATION OF SERIES 2019-VF1 NOTES .......................................1
SECTION 2. DEFINED TERMS..................................................................................2
SECTION 3. FORMS OF SERIES 2019-VF1 NOTES.............................................13
SECTION 4. COLLATERAL VALUE EXCLUSIONS.............................................13
SECTION 5. ADMINISTRATIVE AGENT...............................................................14
SECTION 6. SERIES RESERVE ACCOUNT...........................................................15
SECTION 7. PAYMENTS; NOTE BALANCE INCREASES; EARLY
MATURITY; ADDITIONAL FUNDING CONDITIONS............................................16
SECTION 8. DETERMINATION OF NOTE INTEREST RATE. 17
SECTION 9. INCREASED COSTS............................................................................17
SECTION 10. SERIES REPORTS..............................................................................19
SECTION 11. CONDITIONS PRECEDENT SATISFIED.......................................20
SECTION 12. REPRESENTATIONS AND WARRANTIES; COVENANTS........20
SECTION 13. AMENDMENTS..................................................................................21
SECTION 14. COUNTERPARTS...............................................................................22
SECTION 15. ENTIRE AGREEMENT.....................................................................22
SECTION 16. LIMITED RECOURSE......................................................................22
SECTION 17. OWNER TRUSTEE LIMITATION OF LIABILITY......................23
SECTION 18. REDUCTION OF MAXIMUM COMMITTED PURCHASE
PRICE...............................................................................................................................23
SECTION 19. ASSIGNMENT.....................................................................................23
SECTION 20. NOTICES.............................................................................................23
SECTION 21. CONDITIONS PRECEDENT TO EFFECTIVENESS OF THIS
INDENTURE SUPPLEMENT.......................................................................................24